Table 2 Comparison of participants’ knowledge of FP options, awareness of fertility centers providing fertility preservation services, and adverse effects of cancer and cancer treatment by age group (< 18, respondent = parents; ≥ 18 respondent = patient)
FP options | < 18 years n (%) | ≥ 18 years n (%) | Siga | |
|---|---|---|---|---|
Embryo cryopreservation | Yes | 3(3.7) | 35 (11.6) | 0.03* |
No | 78(96.3) | 268 (88.4) | ||
Ovarian tissue cryopreservation | Yes | 4 (4.9) | 30 (9.9) | 0.19 |
No | 77 (95.1) | 272 (90.1) | ||
Oocyte cryopreservation | Yes | 4 (4.9) | 34 (11.3) | 0.09 |
No | 77 (95.1) | 268 (88.7) | ||
Ovarian transposition | Yes | 3 (3.7) | 30 (10) | 0.07 |
No | 78 (96.3) | 271 (90) | ||
gonadotropin releasing hormones (GnRH) | Yes | 1 (1.2) | 17 (5.7) | 0.13 |
No | 80 (98.8) | 282 (94.3) | ||
Sperm cryopreservation | Yes | 2 (2.5) | 33 (11) | 0.01* |
No | 79 (97.5) | 268 (89) | ||
Testicular tissue cryopreservation | Yes | 2 (2.5) | 22 (7.3) | 0.12 |
No | 79 (97.5) | 278 (92.7) | ||
Awareness | ||||
Side effects of cancer treatments on fertility | Yes | 21 (26.3) | 41 (14.1) | 0.01* |
No | 59 (73.8) | 250 (85.9) | ||
The possibility of transferring genes and traits attributed to cancer to the next generation | Yes | 25 (30.9) | 116 (39.3) | 0.16 |
No | 56 (69.1) | 179 (60.7) | ||
Fertility clinics providing fertility preservation services | Yes | 8 (9.9) | 70 (23.3) | 0.008* |
No | 73 (90.1) | 231(76.7) | ||